Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.947 |
High Similarity |
NPD7075 |
Discontinued |
0.9459 |
High Similarity |
NPD4380 |
Phase 2 |
0.94 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.9384 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9272 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9205 |
High Similarity |
NPD6801 |
Discontinued |
0.9103 |
High Similarity |
NPD1549 |
Phase 2 |
0.9091 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.9079 |
High Similarity |
NPD1934 |
Approved |
0.9057 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.9034 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9034 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8987 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8987 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8987 |
High Similarity |
NPD6166 |
Phase 2 |
0.8926 |
High Similarity |
NPD6799 |
Approved |
0.8839 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8836 |
High Similarity |
NPD2796 |
Approved |
0.8782 |
High Similarity |
NPD3882 |
Suspended |
0.8767 |
High Similarity |
NPD1510 |
Phase 2 |
0.8766 |
High Similarity |
NPD7411 |
Suspended |
0.8742 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8701 |
High Similarity |
NPD6599 |
Discontinued |
0.8684 |
High Similarity |
NPD1512 |
Approved |
0.8654 |
High Similarity |
NPD7819 |
Suspended |
0.8654 |
High Similarity |
NPD2801 |
Approved |
0.8627 |
High Similarity |
NPD5403 |
Approved |
0.8621 |
High Similarity |
NPD1240 |
Approved |
0.8599 |
High Similarity |
NPD3817 |
Phase 2 |
0.8598 |
High Similarity |
NPD6797 |
Phase 2 |
0.8553 |
High Similarity |
NPD1511 |
Approved |
0.8545 |
High Similarity |
NPD6559 |
Discontinued |
0.8545 |
High Similarity |
NPD7251 |
Discontinued |
0.8537 |
High Similarity |
NPD7074 |
Phase 3 |
0.8528 |
High Similarity |
NPD3818 |
Discontinued |
0.8503 |
High Similarity |
NPD1607 |
Approved |
0.85 |
High Similarity |
NPD5494 |
Approved |
0.8497 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8494 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8481 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8476 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8447 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8428 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8424 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8405 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8383 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8289 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8263 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8253 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8235 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.817 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8117 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8092 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8092 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8061 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8038 |
Intermediate Similarity |
NPD920 |
Approved |
0.8037 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8024 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8023 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD919 |
Approved |
0.7987 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7953 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7935 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7929 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7911 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7911 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7911 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7908 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7885 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7871 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7867 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7809 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7809 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7798 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7792 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7763 |
Intermediate Similarity |
NPD943 |
Approved |
0.7748 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7738 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7733 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.773 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7716 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7701 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7701 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7677 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7677 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.767 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7651 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7643 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7628 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7628 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7622 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7597 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7597 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7582 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7568 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.755 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7484 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7484 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7473 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7473 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7473 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7473 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7473 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7469 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7469 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7452 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7442 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7433 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7433 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7427 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7427 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7423 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7419 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7418 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7418 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7416 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7391 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7389 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7372 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7341 |
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7338 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD1653 |
Approved |
0.733 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7316 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7303 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7297 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7297 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7292 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7267 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7262 |
Intermediate Similarity |
NPD37 |
Approved |
0.7251 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.725 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7235 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7235 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7234 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.723
|
Intermediate Similarity |
NPD9545 |
Approved |